Dr Sheela Moorthy, MD | |
1001 S George St, York, PA 17403-3676 | |
(717) 851-2613 | |
(717) 851-2602 |
Full Name | Dr Sheela Moorthy |
---|---|
Gender | Female |
Speciality | Pediatrics - Neonatal-perinatal Medicine |
Location | 1001 S George St, York, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053547059 | NPI | - | NPPES |
102756964 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD438184 (Pennsylvania) | Secondary |
2080N0001X | Pediatrics - Neonatal-perinatal Medicine | MD438184 (Pennsylvania) | Primary |
Entity Name | Childrens Health Care Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598869059 PECOS PAC ID: 1355253527 Enrollment ID: O20040216001108 |
News Archive
Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.
Compared to conventional chemotherapy, autologous stem cell transplantation can extend "event-free survival" for breast cancer patients. Clinical trials provide proof of this for breast cancer with and without distant metastases. However, there are indications that this type of stem cell transplantation can more frequently give rise to severe complications affecting almost all organ systems. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 December 2009.
Biodel Inc. today announced that it has entered into a definitive securities purchase agreement with a group of institutional investors, including both existing and new investors, for the private placement of approximately 7.9 million shares of its capital stock and warrants to purchase approximately 2.7 million shares of its common stock.
Research just published that identifies new highly antibiotic-resistant bacteria reinforces the frequency with which similar strains of so-called "superbugs" are being discovered across Europe, according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
A protein that regulates cholesterol levels in the body also is responsible for maintaining a healthy balance between fat storage and fat burning, according to a UT Southwestern Medical Center study that may lead to new drug targets in the fight against obesity.
› Verified 7 days ago
Entity Name | Wellspan Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.
Compared to conventional chemotherapy, autologous stem cell transplantation can extend "event-free survival" for breast cancer patients. Clinical trials provide proof of this for breast cancer with and without distant metastases. However, there are indications that this type of stem cell transplantation can more frequently give rise to severe complications affecting almost all organ systems. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 December 2009.
Biodel Inc. today announced that it has entered into a definitive securities purchase agreement with a group of institutional investors, including both existing and new investors, for the private placement of approximately 7.9 million shares of its capital stock and warrants to purchase approximately 2.7 million shares of its common stock.
Research just published that identifies new highly antibiotic-resistant bacteria reinforces the frequency with which similar strains of so-called "superbugs" are being discovered across Europe, according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
A protein that regulates cholesterol levels in the body also is responsible for maintaining a healthy balance between fat storage and fat burning, according to a UT Southwestern Medical Center study that may lead to new drug targets in the fight against obesity.
› Verified 7 days ago
Entity Name | St Joseph Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184754657 PECOS PAC ID: 3779688650 Enrollment ID: O20070421000011 |
News Archive
Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.
Compared to conventional chemotherapy, autologous stem cell transplantation can extend "event-free survival" for breast cancer patients. Clinical trials provide proof of this for breast cancer with and without distant metastases. However, there are indications that this type of stem cell transplantation can more frequently give rise to severe complications affecting almost all organ systems. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 December 2009.
Biodel Inc. today announced that it has entered into a definitive securities purchase agreement with a group of institutional investors, including both existing and new investors, for the private placement of approximately 7.9 million shares of its capital stock and warrants to purchase approximately 2.7 million shares of its common stock.
Research just published that identifies new highly antibiotic-resistant bacteria reinforces the frequency with which similar strains of so-called "superbugs" are being discovered across Europe, according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
A protein that regulates cholesterol levels in the body also is responsible for maintaining a healthy balance between fat storage and fat burning, according to a UT Southwestern Medical Center study that may lead to new drug targets in the fight against obesity.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sheela Moorthy, MD 3421 Concord Rd, York, PA 17402-9001 Ph: (717) 851-2613 | Dr Sheela Moorthy, MD 1001 S George St, York, PA 17403-3676 Ph: (717) 851-2613 |
News Archive
Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.
Compared to conventional chemotherapy, autologous stem cell transplantation can extend "event-free survival" for breast cancer patients. Clinical trials provide proof of this for breast cancer with and without distant metastases. However, there are indications that this type of stem cell transplantation can more frequently give rise to severe complications affecting almost all organ systems. This is the conclusion of the final report of the Institute for Quality and Efficiency in Health Care (IQWiG) published on 16 December 2009.
Biodel Inc. today announced that it has entered into a definitive securities purchase agreement with a group of institutional investors, including both existing and new investors, for the private placement of approximately 7.9 million shares of its capital stock and warrants to purchase approximately 2.7 million shares of its common stock.
Research just published that identifies new highly antibiotic-resistant bacteria reinforces the frequency with which similar strains of so-called "superbugs" are being discovered across Europe, according to the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
A protein that regulates cholesterol levels in the body also is responsible for maintaining a healthy balance between fat storage and fat burning, according to a UT Southwestern Medical Center study that may lead to new drug targets in the fight against obesity.
› Verified 7 days ago
Dr. Yvette Yamcek-meleka, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2339 S George St, York, PA 17403 Phone: 717-812-3040 Fax: 717-812-3049 | |
Dr. Furman Titus Updike Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2062 Wyntre Brooke Dr, York, PA 17403 Phone: 717-815-0505 | |
Samira Kannarkatt, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2050 S Queen St Ste 100, York, PA 17403 Phone: 717-812-4240 Fax: 717-848-5520 | |
Alexa Laudenslager, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2675 Joppa Rd, York, PA 17403 Phone: 717-741-9063 Fax: 717-718-9779 | |
Dr. Pamela Faith Mccarter, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 605 S George St, Ste 200, York, PA 17401 Phone: 717-851-2334 Fax: 717-851-3498 | |
Kelly Curtin-hallinan, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 2003 E Market St, York, PA 17402 Phone: 717-812-4242 Fax: 717-755-7569 |